PATENT CLAIM ANALYSIS

Application Number: 16130898
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "289000"]

Abstract:
Dosage forms, drug delivery systems, methods related to sustained release of dextromethorphan or improved therapeutic effects, and methods of the use of bupropion and dextromethorphan for treating nicotine addiction are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claim (Index 8):
The method of  claim 1 , wherein about 10 mg to about 20 mg of the dextromethorphan is administered to the person daily.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 97.0
- Lexical Diversity: 1.5641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15164746', '15621882', '15647069', '15645939', '15688660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.901279350054574
- 35 USC 102 Novelty (BERT): 0.7095441090651725
- Combined Prediction Score: 0.8821058259556339
- Mean Citation Score: 711.6267
- Max Citation Score: 718.4103
- Similarity Product: 596.8894029898881

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test